Alle Artikel zum Thema Studiendaten - Handelszeitung

Alle Stichwörter

Studiendaten

ANKARA, TURKEY - OCTOBER 27: A health care worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate, within the scope of phase 3 studies, was injected to volunteers in Ankara University Ibni Sina Hospital. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)

ANKARA, TURKEY - OCTOBER 27: A health care worker holds an injection syringe of the phase 3 vaccine trial, developed against the novel coronavirus (COVID-19) pandemic by the U.S. Pfizer and German BioNTech company, at the Ankara University Ibni Sina Hospital in Ankara, Turkey on October 27, 2020. This vaccine candidate, within the scope of phase 3 studies, was injected to volunteers in Ankara University Ibni Sina Hospital. (Photo by Dogukan Keskinkilic/Anadolu Agency via Getty Images)

Covid-19-Impfung: Biontech mit positiven Daten – Börse feiert

Noch im November soll der Antrag in den USA eingereicht werden. Die Aussicht auf eine Impfung löst ein Kursfeuerwerk an den Börsen aus. Mehr…

Publiziert am 09.11.2020

Biontech Covid-19

Biontech Covid-19

Biontech treibt Corona-Impfstoffprojekt voran

Die deutsche Biotech-Firma startet Ende Juli die klinische Studie für ihren Impfstoff. Weltweit werden 17-Coronaimpfstoffe am Menschen getestet. Mehr…

Publiziert am 01.07.2020